Unity Biotechnology Statistics
Total Valuation
UNBX has a market cap or net worth of 1.51 million. The enterprise value is 7.19 million.
| Market Cap | 1.51M |
| Enterprise Value | 7.19M |
Important Dates
The last earnings date was Tuesday, July 29, 2025.
| Earnings Date | Jul 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
UNBX has 17.21 million shares outstanding. The number of shares has increased by 9.47% in one year.
| Current Share Class | 17.21M |
| Shares Outstanding | 17.21M |
| Shares Change (YoY) | +9.47% |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | 1.43% |
| Owned by Institutions (%) | 9.17% |
| Float | 15.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -7.37 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.26 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.95
| Current Ratio | 1.95 |
| Quick Ratio | 1.87 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -231.27% and return on invested capital (ROIC) is -47.83%.
| Return on Equity (ROE) | -231.27% |
| Return on Assets (ROA) | -38.89% |
| Return on Invested Capital (ROIC) | -47.83% |
| Return on Capital Employed (ROCE) | -130.44% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -1.72M |
| Employee Count | 16 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -94.41% in the last 52 weeks. The beta is 0.85, so UNBX's price volatility has been lower than the market average.
| Beta (5Y) | 0.85 |
| 52-Week Price Change | -94.41% |
| 50-Day Moving Average | 0.26 |
| 200-Day Moving Average | 1.05 |
| Relative Strength Index (RSI) | 39.25 |
| Average Volume (20 Days) | 124,695 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.31 |
Income Statement
| Revenue | n/a |
| Gross Profit | -12.06M |
| Operating Income | -27.76M |
| Pretax Income | -27.50M |
| Net Income | -27.50M |
| EBITDA | -26.94M |
| EBIT | -27.76M |
| Earnings Per Share (EPS) | -1.63 |
Balance Sheet
The company has 16.93 million in cash and 22.61 million in debt, giving a net cash position of -5.67 million or -0.33 per share.
| Cash & Cash Equivalents | 16.93M |
| Total Debt | 22.61M |
| Net Cash | -5.67M |
| Net Cash Per Share | -0.33 |
| Equity (Book Value) | -205,000 |
| Book Value Per Share | -0.01 |
| Working Capital | 8.58M |
Cash Flow
| Operating Cash Flow | -22.04M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
UNBX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.47% |
| Shareholder Yield | n/a |
| Earnings Yield | -1,819.84% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 20, 2022. It was a reverse split with a ratio of 0.1.
| Last Split Date | Oct 20, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |